NEW YORK, NY / ACCESS Newswire / February 9, 2025 / If you suffered a loss on your Crocs, Inc. (NASDAQ:CROX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/crocs-inc-lawsuit-submission-form?prid=128315&wire=1 or contact Joseph E. Levi, Esq.

RADNOR, Pa. , Feb. 9, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against Crocs, Inc. (NASDAQ: CROX) ("Crocs" or the "Company") on behalf of investors who purchased or otherwise acquired Crocs common stock between November 3, 2022, and October, 28 2024, inclusive (the "Class Period").

Philip Morris delivered strong Q4 results, surpassing EPS and revenue estimates, driven by surging demand for non-traditional products like IQOS and ZYN. Non-traditional products now represent 40% of total revenue, significantly boosting gross profits. Despite strong performance and profitability, I maintain a hold rating due to Philip Morris' high valuation with a forward P/E ratio of 18.7X.

LendingClub's stock fell 20% post-earnings due to mixed results and guidance, presenting a buying opportunity for long-term investors. Despite concerns over loan origination growth, LC focuses on high credit quality and prudent growth, aiming for >$2.3 billion in 2025. Valuation remains low, and if 2025 guidance is conservative, the stock could see significant upside, currently trading at ~1.2x book value.

T-Mobile is heading to the Super Bowl to show off its space ambitions, with a widespread launch slated for July.

Argan, Inc. is a buy due to its energy-agnostic business model, robust growth, and strong balance sheet, despite high valuation risks. AGX has seen over 300% revenue growth in five years, with significant project wins and a growing backlog, driving stock performance. The company pays a growing dividend, indicating confidence in its financial health and future growth potential.

Farmer Bros.: Turnaround Play Trading At Deeply Discounted Valuation - Buy (Rating Upgrade)

Last week, Aurora Cannabis reported blowout Q3/FY2025 results with sales, gross margins, profitability, and free cash flow reaching new all-time highs. As a leader in the medical cannabis space, the company is enjoying premium margins. Following the descheduling of cannabis in Germany last year, sales in Europe have increased substantially. Cash, restricted cash and cash equivalents increased to $180.2 million. The company's core cannabis operations remain debt free.

A first-of-its-kind Super Bowl moment blends an anthemic ad with a live stadium singalong, uniting Americans in a call to come home DETROIT , Feb. 9, 2025 /PRNewswire/ -- Rocket Companies (NYSE: RKT), the Detroit-based fintech platform company consisting of mortgage, real estate and personal finance businesses, tonight launched its Own the Dream integrated marketing campaign during the second quarter of Super Bowl LIX. The company's ad spot turned into a nationwide singalong, bringing millions of Americans together.

AMD's Q4 report showed mixed results, but the company is poised for strong future growth with upcoming AI GPU upgrades, particularly the MI350 series. Data Center revenues now exceed 50% of AMD's total, positioning the company for significant growth despite weaknesses in Embedded and Gaming sectors. AMD's AI GPU revenue is expected to surge from $5 billion in 2024 to over $20 billion in future years, driven by increased Data Center spending.

NEW YORK, NY / ACCESS Newswire / February 9, 2025 / If you suffered a loss on your Cassava Sciences, Inc. (NASDAQ:SAVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cassava-sciences-inc-lawsuit-submission-form?prid=128314&wire=1 or contact Joseph E. Levi, Esq.

India expects stable delivery of a domestically-made light combat aircraft powered by a GE engine in the upcoming fiscal year after a delay of nearly 12 months, a top government official said on Sunday.

NEW YORK, NY / ACCESS Newswire / February 9, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/neumora-therapeutics-inc-lawsuit-submission-form?prid=128312&wire=1 or contact Joseph E. Levi, Esq.

T-Mobile said on Sunday it has started wide-scale testing of its satellite-to-cell service, powered by SpaceX's Starlink, as the U.S. wireless carrier aims to eliminate mobile dead zones and extend connectivity to remote areas.

BELLEVUE, Wash.--(BUSINESS WIRE)--Minutes ago, during the country's largest annual sporting event, T-Mobile (NASDAQ: TMUS) introduced the next big thing in wireless — T-Mobile Starlink — to tens of millions of football fans. Now in public beta, this breakthrough service, developed in partnership with Starlink, uses straight-out-of-a-sci-fi-movie satellite and mobile communications technology to help keep people connected — even you, Verizon and AT&T customers — in the more than 500,000 squa.

Japan's Nippon Steel on Monday declined to comment on U.S. President Donald Trump's statement that no one can have a majority stake in U.S. Steel.

JPMorgan Chase has named two longtime executives to oversee its banking business. Matt Sable and Melissa Smith have been named co-heads of commercial banking, the lender said in a news release provided to PYMNTS Friday (Feb. 7).

NEW YORK, NY / ACCESS Newswire / February 9, 2025 / If you suffered a loss on your Cassava Sciences, Inc. (NASDAQ:SAVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cassava-sciences-inc-lawsuit-submission-form?prid=128311&wire=1 or contact Joseph E. Levi, Esq.

Investors looking for the best artificial intelligence (AI) stocks might want to look at the companies Wall Street is overlooking right now. Some tech leaders in hardware and software are experiencing strong demand for their technology but, for whatever reason, are not seeing validation yet in their share price.

NEW YORK, NY / ACCESS Newswire / February 9, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/regeneron-pharmaceuticals-inc-lawsuit-submission-form?prid=128308&wire=1 or contact Joseph E. Levi, Esq.